Hims & Hers Stock Slips Amid Wegovy Competition: What Investors Should Know in 2026 | MarketWire
Hims & Hers stock is down as it faces mounting pressure from Novo Nordisk's weight-loss treatment leadership. Here’s what this means for investors navigating the market.